These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Association of negative symptoms with tardive dyskinesia in schizophrenic patients. Chiu H; Lau J; Lam L; Shum P Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320 [TBL] [Abstract][Full Text] [Related]
5. [Schizophrenic deficit syndrome and neurologic tolerance]. Verdoux H; Bourgeois M Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042 [TBL] [Abstract][Full Text] [Related]
6. Tardive dyskinesia and perceptual dysfunction. Donnelly EF; Jeste DV; Wyatt RJ Percept Mot Skills; 1981 Dec; 53(3):689-90. PubMed ID: 6119676 [TBL] [Abstract][Full Text] [Related]
7. [Psychopathology and cognitive disorders in chronic schizophrenic patients with tardive dyskinesia]. Kaiser W Nervenarzt; 1989 Apr; 60(4):206-12. PubMed ID: 2566936 [No Abstract] [Full Text] [Related]
8. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253 [TBL] [Abstract][Full Text] [Related]
14. [Dimethylaminoethanol in the treatment of neuroleptic-induced tardive dyskinesia]. Lambert PA; Wolff P; de Maximy B; Ghenim A Ann Med Psychol (Paris); 1978 Apr; 136(4):625-9. PubMed ID: 31832 [No Abstract] [Full Text] [Related]
15. Neuroleptic malignant syndrome after neuroleptic discontinuation. Amore M; Zazzeri N Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212 [TBL] [Abstract][Full Text] [Related]
16. [Utility of quetiapine in tardive dyskinesia]. Navarro Pacheco BV; Montejo González AL; Martín Carrasco M Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511 [TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia in young mentally retarded individuals. Gualtieri CT; Schroeder SR; Hicks RE; Quade D Arch Gen Psychiatry; 1986 Apr; 43(4):335-40. PubMed ID: 2869741 [TBL] [Abstract][Full Text] [Related]
18. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness. Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460 [TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia. Chan HY; Chiang SC; Chang CJ; Gau SS; Chen JJ; Chen CH; Hwu HG; Lai MS J Clin Psychiatry; 2010 Sep; 71(9):1226-33. PubMed ID: 20441726 [TBL] [Abstract][Full Text] [Related]
20. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia. Liddle PF; Barnes TR; Speller J; Kibel D Br J Psychiatry; 1993 Dec; 163():776-80. PubMed ID: 7905774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]